Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Devices

Biophan Technologies Inc

+ Add to Watchlist


0.0005 USD 0.0001 25.00%

As of 20:10:03 ET on 05/29/2015.

Snapshot for Biophan Technologies Inc (BIPH)

Open: 0.0006 Day's Range: 0.0005 - 0.0006 Volume: 148,600
Previous Close: 0.0004 52wk Range: 0.0004 - 0.0014 1-Yr Rtn: -60.00%

Stock Chart for BIPH

No chart data available.
  • BIPH:US 0.0005
  • 1D
  • 1M
  • 1Y
Interactive BIPH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for BIPH

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -0.0320
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 0.13
Shares Outstanding (M) 238.36
30 Day Average Volume 29,911
Price/Book (mrq) 0.0948
Price/Sale (ttm) 0.1458
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for BIPH

No data available

Company Profile & Key Executives for BIPH

Biophan Technologies, Inc. holds the rights to several medical inventions and patents. The Company holds pending patents for an implantable cardiac pacemaker designed to withstand a magnetic resonance imaging energy field, known as an MRI compatible pacemaker. Biophan also holds several issued patents for the use of antisense technology to block the HIV virus.

Stanley Yakatan "Stan"ChairmanJohn F LanzafamePresident/CEO
Margaret V RussellCFO/Secretary/Treasurer
More Company Profile & Key Executives for BIPH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil